10:17 AM EST - Appili Therapeutics Inc. : Today announced that, the Company along with its partners, have submitted applications for four new federal funding opportunities. The funding, if awarded, would total up to US$117.5 million and support the company’s efforts to advance urgent infectious disease treatments aligned with critical public health priorities. Appili Therapeutics Inc.
shares T.APLI are trading unchanged at $0.03.
